Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)








Study Syllabus for Classification of Radiographs of Pneumoconioses						Print
																Related Pages
										Clinical OverviewMajor Occupational Lung DiseasesGranulomatous Diseases
Chronic Beryllium Disease
Chronic beryllium disease (CBD) is an immune-mediated granulomatous lung disease resembling sarcoidosis that is caused by exposure to the lightweight metal beryllium. Exposure can occur in a number of industries including aerospace, defense, metal machining, electronics manufacture and recycling, and dental alloy/appliance production. Diagnosis requires a history of beryllium exposure; a positive blood or bronchoalveolar lavage (BAL) beryllium lymphocyte proliferation test (BeLPT); and noncaseating granulomas and/or mononuclear cell infiltrates on lung biopsy. A patient is considered beryllium sensitized when they have a positive blood BeLPT but no abnormal lung pathology. When histopathology is unavailable, a CBD diagnosis can be made based on the exposure history, a positive BeLPT, and imaging that shows abnormalities consistent with CBD. In early CBD, pulmonary function abnormalities, if present, include mild airflow limitation and abnormal gas exchange at rest or with exercise. Diffusing capacity (DLCO) may be low, and arterial blood gas analysis with exercise may show gas exchange abnormalities. With more advanced disease, PFTs show airflow limitation, restriction or a mixed pattern.
In early disease, the chest radiograph may be normal or show hilar adenopathy or parenchymal abnormalities. Parenchymal abnormalities include nodules (Fig. 16), ground glass, linear or alveolar opacities. The parenchymal abnormalities may be diffuse or upper lobe predominant. HRCT is more sensitive than chest x-ray in diagnosing CBD, however, HRCT is normal in up to 25% of patients with biopsy-proven CBD [Newman et al. 1994].
HRCT findings of CBD include parenchymal nodules of varying size, thickened septal lines, ground glass opacities, cystic cavitation, bronchial wall thickening, and hilar/mediastinal adenopathy [Newman et al. 1994; Naccache et al. 2003].
The lack of effective treatment, the progressive nature of the disease with on-going exposure, and the severity of fixed obstruction often seen in affected workers underscore the need for early recognition and control of causal exposures.
Chest radiographs are generally normal in early disease stages, but may show hyperinflation. Characteristic findings on HRCT include segmental or lobular areas of hypo-attenuation (air trapping) associated with narrowing of pulmonary vessels (mosaic perfusion), usually accentuated on expiratory images (Fig. 13).HYPERSENSITIVITY PNEUMONITISPage 6 of 6DIAGNOSTIC IMAGING
							
					
							Last Reviewed:  April 26, 2023						Source: 	National Institute for Occupational Safety and Health
					Facebook
        Twitter
        LinkedIn
        Syndicate homeStudy Syllabus for Classification of Radiographs of Pneumoconioses
Introductionplus icon
Preface
Appreciation to Contributors
Intent of the Self-study Syllbus
Getting Started
Clinical Overviewplus icon
Major Occupational Lung Diseasesplus icon
Pneumoconioses
Central Role of Diagnostic Imagingplus icon
Role of CT
Overview of Nonimaging Clinical Tools in Lung Disease Diagnosis
Appendix A
References
Pathology Overviewplus icon
Pulmonary Silicosis
Coal Workers’ Pneumoconiosis
Asbestos Pleuropulmonary Disease
Pathological-Clinical Correlations
References
Radiograph Classificationplus icon
SUBSET 1 – Radiograph Classification, #1 to #19plus icon
Introduction
Radiograph Identification
Section 1: Image Quality
Section 2: Parenchymal Abnormalities, #1 to #14
Section 3: Pleural Abnormalities, #15 to #19
Section 4: Any Other Abnormalities
Section 5
SUBSET 2 – Radiograph #20 to #27plus icon
Radiograph #20
Radiograph #21
Radiograph #22
Radiograph #23
Radiograph #24
Radiographs #25 to #27
SUBSET 3 – Radiograph #28 to #38plus icon
Radiographs #28 to #30
Radiographs #31 to #32
Radiographs #33 to #35
Radiographs #36 to #38
SUBSET 4 – Radiograph #39 to #46 (Small and Large Opacities)plus icon
Radiographs #39 to #40
Radiographs #41 to #42
Radiographs #43 to #44
Radiograph #45
Radiograph #46
SUBSET 5 – Classifications and Answer Keys, Radiographs #47 to #83
Quiz Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue